PharmaBoardroom

Anne-Laure Dreno – Country President, AstraZeneca Belgium…

Anne-Laure Dreno, country president of AstraZeneca in Belgium, elaborates on the significant position Belgium and the local affiliate have for the…

Pierre Behnam – General Manager, Pierre Fabre Morocco

Pierre Behnam, general manager of Pierre Fabre in Morocco, breaks down the strong and long-standing footprint of the group in the country in the…

Roxana Botea – Country Manager, ViiV Healthcare Belgium…

Roxana Botea, country manager of ViiV Healthcare in Belgium and Luxembourg, shares her experience joining the organization after a long career…

Myriem Tamimy – Country Manager Morocco, Tunisia &…

Myriem Tamimy gives an overview of the ongoing situation for Janssen and pharma multinationals more generally in Morocco, discusses the next steps in…

Glenn Vaughan – Advisor, British Chamber of Commerce | EU…

Glenn Vaughan of the British Chamber of Commerce | EU & Belgium discusses the importance of the Belgium-UK relationship, the role of healthcare…

Christian Schuhmacher – CEO, King’s College Hospital UAE

One year after King’s College Hospital’s establishment in the UAE, CEO Christian Schuhmacher discusses the hospital’s unique approach of…

Romuald Gaudefroy – Managing Director, CAF-DCF, Belgium

Romuald Gaudefroy, managing director of CAF-DCF, the Belgian subsidiary of the LFB Group, introduces the company which was integrated into LFB in…

Ousama Al Haj – Director UAE, Bahrain, Oman & Qatar…

Ousama Al Haj, director for UAE, Bahrain, Oman & Qatar at AstraZeneca, highlights the company’s substantial growth and favourable position in…

Brain Drain: A Ticking Time Bomb for Romanian Healthcare

According to a 2015 United Nations International Migration Report, since Romania joined the European Union in 2007, around 3.4 million Romanians have…

Romania: Europe’s Most Challenging Market for Generics?

While the dismal regulatory environment in Romania has negatively affected the innovators with the uncertain and lengthy regulatory approval timelines…

5 Cell & Gene Companies to Watch in South Korea

South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Jingsong Wang – Chairman & CEO, Harbour BioMed, China

PharmaBoardroom caught up with Dr Jingsong Wang, chairman & CEO of Harbour BioMed to discuss the exciting clinical and commercial milestones of…

Sign in

Tagged with